http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019155195-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2bca89c12bc5ca393d6e0d33f1e7d109
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_82720f0fe09c6d788db8fde9be2350dc
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0261
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0279
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0273
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2039-0291
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2005-4455
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-0247
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F5-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M39-02
filingDate 2019-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bfa88990a96f7d66dd13f7acea07cc2c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7af532fe37c63a6806c6231294fafdd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39340c442c8bfcf1b137c87b69e725d4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81bcb6162c88ffdcc83e20d81508ef72
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87e964a62b82cf4073569b6cb5073f1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df69436433f1b40214e596e2da617c3d
publicationDate 2019-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2019155195-A1
titleOfInvention Transcutaneous port and method for manufacture
abstract The invention provides a transcutaneous port which promotes tissue integration for anchoring in the skin and which reduces the risk of infection. The transcutaneous port of the invention comprises a port body (1) having an external end (2a) and a subcutaneous end (2b) and at least one channel (5) which extends longitudinally through the port body. The port body (1) comprises a first impermeable portion (3) extending longitudinally from the external end (2a) and a mesh portion (4) extending longitudinally from the subcutaneous end (2b) of the port body (1). The thickness of the mesh portion (4) has a smaller thickness T1 proximate to the first impermeable portion (3) of the port body (1) and a larger thickness T2 proximate to the subcutaneous end (2b) of the port body (1). The thicker part of the mesh portion (4) is suitable for contacting the dermis when the transcutaneous port is implanted. The invention further relates to a method of manufacturing the transcutaneous port and a method of implanting the port in the human or animal body.
priorityDate 2018-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4578063-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0343114-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419555779
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559477
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23963
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945

Total number of triples: 31.